1. PICCO, M. F. u. J. R. CANGEMI (2009):
Inflammatory bowel disease in the elderly Gastroenterol Clin North Am 30, 409-426
2. BERNSTEIN, C. N., M. D., J. F. BLANCHARD M.D., PH. D., E. KLIEWER, PH. D., A. WAJDA, M. S. (2001):
Cancer risk in patients with inflammatory bowel disease Cancer 91, 854-862
3. TRAVIS, S. P. L., E.F. STANGE, M. LÉMANN, T. ØRESLAND, W. A. BEMELMAN, Y. CHOWERS, J. F. COLOMBEL, G. D'HAENS, S. GHOSH, P. MARTEAU, W.
KRUIS, N. J. M. C. MORTENSEN, F. PENNINCKX u. M. GASSULL (2008):
European evidence-based Consensus on the management of ulcerative colitis:
Current management
Journal of Crohn’s and Colitis 2, 24-62
4. FORABOSCO, P., A. COLLINS, A. LATIANO, V. ANNESE, M. CLEMENTI, A.
ANDRIULLI, P. FORTINA, M. DEVOTO u. N. E. MORTON (2000):
Combined segregation and linkage analysis of inflammatory bowel disease in the IBD1 region using severity to characterise Crohn's disease and ulcerative colitis. On behalf of the GISC.
Eur J Hum Genet. 8, 846-52
5. LAKATOS, L., T. PANDUR, G. DAVID, Z. BALOGH, P. KARONYA, A. TOLLAS u.
P. L. LAKATOS (2003):
Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: Results of a 25-year follow-up study
World J Gastroenterol 9, 2300-2307 6. HUGOT, J. P., PROF. (2004):
Inflammatory bowel disease: a complex group of genetic disorders Clinical Gastroenterology 18, 451-462
7. CARIO, E. u. D. K. PODOLSKY (2005):
Intestinal epithelial Tollerance versus inTollerance of commensals Mol Immunol 42, 887-893
8. MUNKHOLM, P., E. LANGHOLZ, D. HOLLANDER, K. THORNBERG, M.
ORHOLM, K. D. KATZ u. V. BINDER (1994):
Intestinal permeability in patients with Crohn's disease and ulcerative colitis and their first degree relatives.
GUT 35, 68-72
9. PROF BERNSTEIN, C. N., PROF. M. FRIED, DR. J. H. KRABSHUIS, PROF. H.
COHEN, PROF. R. ELIAKIM, PROF. S. FEDAIL, DR. R. GEARRY, PROF. K. L.
GOH, PROF. S. HAMID, DR. A. G. KHAN, PROF. MALFERTHEINER, PROF. J. F.
REY, DR. A. SOOD, PROF. F. STEINWURZ, DR. O. O. THOMSEN, DR. A.
THOMSEN u. DR. G. WATERMEYER (2010):
World Gastroenterology Organization Practice Guidelines for the Diagnosis and Management of IBD in 2010
Inflammatory Bowel Disease 16, 112-124 10. LOFTUS JR., E. V. (2004):
Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences
Gastroenterology 126, 1504-1517
11. CROHN, B. B., M. D., L. GINZBURG, M. D. u. G. D. OPPENHEIMER, M. D.
(1932):
Regional ileitis
Journal of the Amarican medical Association 99, 1323-1329
12. ORHOLM, M., M. D., P. MUNKHOLM, M. D., E. LANGHOLZ, M. D., O. H.
NIELSEN, T. I. A. SØRENSEN u. V. BINDER (1991):
Familial Occurrence of Inflammatory Bowel Disease N Engl J Med 324, 84-88
13. VERMEIRE, S., M. PEETERS, R. VLIETINCK, S. JOOSSENS, E. DEN HOND, V.
BULTEEL, X. BOSSUYT, B. GEYPENS, PROF. DR. P. RUTGEERTS (2001):
Anti-Saccharomyces Cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: A study in IBD families
Inflammatory Bowel Disease 7, 8-15
14. HALFVARSON, J., L.BODIN, C. TYSK, E. LINDBERG u. G. JÄRENEROT (2003):
Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics
Gastroenterology 124, 1767-1773
15. ORHOLM, M., V. BINDER, T. I. A. SØRENSEN, L. P. RASMUSSEN, K. O.
KYVIK (2000):
Concordance of Inflammatory Bowel Disease among Danish Twins: Results of a Nationwide Study
Scand J Gastroenterol 35, 1075-1081
16. HALFVARSON, J., M. D., Ph. D., T. JESS, M. D., L. BODIN, Ph. D., G.
JÄRNEROT, M. D., Ph. D., P. MUNKHOLM, M. D., V. BINDER, M. D., C. TYSK u. M.
D., Ph. D. (2007):
Longitudinal concordance for clinical characteristics in a Swedish-Danish twin population with inflammatory bowel disease
Inflammatory Bowel Disease 13, 1536–1544
17. OGURA, Y., D. K. BONEN, N. INOHARA, D. L. NICOLAE, F. F. CHEN, R.
RAMOS, H. BRITTON, T. MORAN, R. KARALIUSKAS, R. H. DUERR, J.-P.
ACHKAR, S. R. BRANT, T. M. BAYLESS, B. S. KIRSCHNER, S. B. HANAUER, G.
NUNEZ u. J. H. CHO (2001):
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease Nature 411, 603-606
18. LESAGE, S., H. ZOUALI, J.-F. COLOMBEL, S. ALMER, C. TYSK, C. O’MORAIN, M. GASSULL, V. BINDER, Y. FINKEL, R. MODIGLIANI, C. GOWER-ROUSSEAU, J.
MACRY, F. MERLIN, M. CHAMAILLARD, A.-S. JANNOT, G. THOMAS, J.-P.
HUGOT (2002):
CARD15/NOD2 Mutational Analysis and Genotype-Phenotype Correlation in 612 Patients with Inflammatory Bowel Disease
Cell 70, Pages 845–857
19. HUGOT, J.-P., M. CHAMAILLARD, H. ZOUALI, S. LESAGE, J.-P. CÉZARD, J.
BELAICHE, S. ALMER, C. TYSK, C. A. O’MORAIN, M. GASSULL, V. BINDER, Y.
FINKEL, A. CORTOT, R. MODIGLIANI, P. LAURENT-PUIG, C. GOWER-ROUSSEAU, J. MACRY, J.-F. COLOMBEL, M. SAHBATOU u. G. THOMAS (2008):
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Nature 411, 599-603
20. ASAKURA, H., M. TSUCHIYA, S. AISO, M. WATANABE, K. KOBAYASHI, T.
HIBI, K. ANDO, H. TAKATA u. S. SEKIGUCHI (1982):
Association of the human lymphocyte-DR2 antigen with Japanese ulcerative colitis.
Gastroenterology, 82, 413-418
21. SUGIMURA, K., H. ASAKURA, N. MIZUKI, M. INOUE, T. HIBI, A. YAGITA, K.
TSUJI u. H. INOKO (1993):
Analysis of genes within the HLA region affecting susceptibility to ulcerative colitis Hum Immunol 36, 112-118
22. FERNANDEZ, L., PH. D., J. L. MENDOZA, PH. D., A. MARTINEZ, PH. D., E.
URCELAY, PH. D., M. FERNANDEZ-ARQUERO, PH. D., J. GARCIA-PAREDES, M.
D., A. S. PENA, M. D., M. DIAZ-RUBIO, M. D., E. G. DE LA CONCHA, M. D., PH. D.
(2004):
IBD1 and IBD3 determine location of Crohn's disease in the Spanish population Inflammatory Bowel Disease 10, 715-722
23. AHMAD, T., A. ARMUZZI, M. BUNCE, K. MULCAHY-HAWES, S. E. MARSHALL, T. R. ORCHARD, J. CRAWSHAW, O. LARGE, A. DE SILVA, J. T. COOK, M.
BARNARDO, S. CULLEN, K. I. WELSH u. D. P. JEWELL (2002):
The molecular classification of the clinical manifestations of Crohn's disease Gastroenterology 122, 854–866
24. SATSANGI, J., J. M. FARRANT, D. P. JEWELL, J. I. BELL, K. I. WELSH, PH. D., M. BUNCEC u. C. JULIER, PH. D. (1996):
Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease
LANCET 347, 1212-1217
25. SILVERBERG, M. S., L. MIREA, S. B. BULL, J. E. MURPHY, A. H. STEINHART, G. R. GREENBERG, R. S. MCLEOD, Z. COHEN, J. A. WADE u. K. A.
SIMINOVITCH (2003):
A population- and family-based study of Canadian families reveals association of HLA DRB1*0103 with colonic involvement in inflammatory bowel disease
Inflammatory Bowel Disease 9, 1-9
26. ORCHARD, T. R., C. N. CHUA, T. AHMAD, K. I. WELSH u. D. P. JEWELL (2002):
Uveitis and erythema nodosum in inflammatory bowel disease: Clinical features and the role of HLA genes
Gastroenterology 123, 714-718
27. VAN HEEL, D. A., I. A. UDALOVA, A. P. DE SILVA, D. P. MCGOVERN, Y.
KINOUCHI, J. HULL, N. J. LENCH, L. R. CARDON, A. H. CAREY, D. P. JEWELL u.
D. KWIATKOWSKI (2002):
Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF-κB transcription factors
Hum Mol Genet 11, 1281-1289
28. TREMELLING, M., S. WALLER, F. BREDIN, S. GREENFIELD, M. PARKES u.
DR. (2006):
Genetic variants in TNF-α but not DLG5 are associated with inflammatory bowel disease in a large United Kingdom cohort
Inflammatory Bowel Disease 12, 178-184
29. PELTEKOVA, V. D., R. F. WINTLE, L. A. RUBIN, C. I. AMOS, Q. HUANG, X. GU, B. NEWMAN M. VAN OENE, D. CESCON, G. GREENBERG, A. M. GRIFFITHS, P.
H. S. GEORGE-HYSLOP u. K. A. SIMINOVITCH (2004):
Functional variants of OCTN cation transporter genes are associated with Crohn disease
Nat Genet 36, 471 – 475
30. MCGOVERN, D. P. B., P. Hysi, T. AHMAD, D. A. VAN HEEL, M. F. MOFFATT, A.
CAREY, W. O. C. COOKSON u. D. P. JEWELL (2005):
Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease
Hum Mol Genet 14, 1245-1250
31. FRANCHIMONT, D., S. VERMEIRE, H. EL HOUSNI, M. PIERIK, K. VAN STEHEN, T. GUSTOT, E. QUERTINMONT, M. ABRAMOWICZ, A. VAN GOSSUM, J.
DEVIÈRE u. P. RUTGEERTS (2004):
Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn’s disease and ulcerative colitis
Gut 53, 987-992
32. DE JAGER, P. L., D. FRANCHIMONT, A. WALISZEWSKA, A. BITTON, A.
COHEN, D. LANGELIER, J. BELAICHE, S. VERMEIRE, L. FARWELL, A. GORIS, C.
LIBIOUELLE, N. JANI, T. DASSOPOULOS, G. P. BROMFIELD, B. DUBOIS, J. H.
CHO, S. R. BRANT, R. H. DUERR, H. YANG, J. I. ROTTER, M. S. SILVERBERG, A.
H. STEINHART, M. J. DALY, D. K. PODOLSKY, E. LOUIS, D. A. HAFLER u. J. D.
RIOUX (2007):
The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases Genes and Immunity 8, 387-397
33. VAN BODEGRAVEN, A. A., C. R. CURLEY, K. A. HUNT, A. J. MONSUUR, R. K.
LINSKENS, C. M. ONNIE, J. B. A. CRUSIUS, V. ANNESE, A. LATIANO, M. S.
SILVERBERG, A. BITTON, S. A. FISHER, A. H. STEINHART, A. FORBES, J.
SANDERSON, N. J. PRESCOTT, D. P. STRACHAN, R. J. PLAYFORD, C. G.
MATHEW, C. WIJMENGA, M. J. DALY, J. D. RIOUX u. D. A. VAN HEEL (2006):
Genetic Variation in Myosin IXB Is Associated With Ulcerative Colitis Gastroenterology 131, 1768-1774
34. KARBAN, A. S., T. OKAZAKI, C. I. M. PANHUYSEN, T. GALLEGOS, J. J.
POTTER, J. E. BAILEY-WILSON, M. S. SILVERBERG, R. H. DUERR, J. H. CHO, P.
K. GREGERSEN, Y. WU, J.-P. ACHKAR, T. DASSOPOULOS, E. MEZEY, T. M.
MAYLESS, F. J. NOUVET u. S. R. BRANT (2004):
Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis
Hum Mol Genet 13, 35-45
35. MATSUMOTO, S., Y. OKABE, H. SETOYAMA, K. TAKAYAMA, J. OHTSUKA, H.
FUNAHASHI, A. IMAOKA u. Y. UMESAKI (1998):
Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strain
Gut 43, 71-78
36. PIZARRO, T. T., K. O. ARSENAU, G. BAMIAS u. F. COMINELLI (2003):
Mouse models for the study of Crohn's disease Trends in Molecular Medicine 9, 218-222
37. NICHOLSON, J. K., E. HOMES u. I. D. WILSON (2005):
Gut microorganisms, mammalian metabolism and personalized health care Nature Reviews Microbiology 3, 431-438
38. RAKOFF-NAHOUM, S., u. R. MEDZHITOV (2006):
Role of the Innate Immune System and Host-Commensal Mutualism Curr Top Microbiol Immunol 308, 1-18
39. SALACK, B., H. MERZ, H. SCHORLE, A. SCHIMPL, A. C. FELLER u. I. HORAK (1993):
Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene.
Cell 22, 253-261
40. SELLON, R. K., S. TONKONOGY, M. SCHULTZ, L. A. DIELEMAN, W.
GRENTHER, E. BALISH, D. M. RENNICK u. R. B. SARTOR (1998):
Resident Enteric Bacteria Are Necessary for Development of Spontaneous Colitis and Immune System Activation in Interleukin-10-Deficient Mice
Infect Immun 66, 5224-5231
41. KÜHN, R., J. LÖHLER, D. RENNICK, K. RAJEWSKI u. W. MÜLLER (1993):
Interleukin-10-deficient mice develop chronic enterocolitis Cell 75, 263–274
42. MORRISSEY, P. J., u. K. CHARRIER (1994):
Induction of wasting disease in SCID mice by the transfer of normal CD4+/CD45RBhi T cells and the regulation of this autoreactivity by CD4+/CD45RBlo T cells
Res Immunol 145, 357-362
43. PANWALA, C. M., J. C. JONES u. J. L. VINEY (1998):
A Novel Model of Inflammatory Bowel Disease: Mice Deficient for the Multiple Drug Resistance Gene, mdr1a, Spontaneously Develop Colitis
J Immunol 15, 5733-5744
44. HANS, W., J. SCHÖLMERICH, V. GROSS u. W. FALK (2000):
The role of the resident intestinal flora in acute and chronic dextran sulfate sodium-induced colitis in mice
Eur J Gastroenterol Hepatol 12, 267-273
45. MADSEN, K. L., J. S. DOYLE, L. D. JEWELL, M. M. TAVERNINI u. R. N.
FEDORAK (1999):
Lactobacillus species prevents colitis in interleukin 10 gene–deficient mice Gastroenterology 116, 1107-1114
46. SCHULTZ, M., M. D., u. R. B. SARTOR, M. D. (2000):
Probiotics and inflammatory bowel diseases Am J Gastroenterol 95, S19-S21
47. JIJON, H., J. BACKER, H. DIAZ, H. YEUNG, C. MCKAIGNEY, C. DE SIMONE u.
K. MADSEN (2004):
DNA from probiotic bacteria modulates murine and human epithelial and immune function
Gastroenterology 126, 1358-1373
48. SCHULTZ, M., u. STRAUCH, U. G., H.-J. LINDE, S. WATZL, F. OBERMEIER, C.
GÖTTL, N. DUNGER, N. GRUNWALD, J. SCHÖLMERICH u. H. C. RATH (2004):
Preventive Effects of Escherichia coli Strain Nissle 1917 on Acute and Chronic Intestinal Inflammation in Two Different Murine Models of Colitis
Clin Vaccine Immunol 11, 372-378
49. GEIER, M. S., R. N. BUTLER, P. M. GIFFARD u. G. S. HOWARTH (2007):
Lactobacillus fermentum BR11, a potential new probiotic, alleviates symptoms of colitis induced by dextran sulfate sodium (DSS) in rats
Int J Food Microbiol 114, 267–274
50. FITZPATRICK, L. R., K. L. HERTZOG, A. L. QUATSE, W. A. KOLTUN, J. S.
SMALL u. K. VRANA (2007):
Effects of the Probiotic Formulation VSL#3 on Colitis in Weanling Rats J Pediatr Gastroenterol Nutr 44, 561-570
51. VAN DER KLEIJ, H., C. O’MAHONY, F. SHANAHAN, L. O’MAHONY u. J.
BIENENSTOCK (2008):
Protective effects of Lactobacillus reuteri and Bifidobacterium infantis in murine models for colitis do not involve the vagus nerve
Am J Physiol 295, R1131-R1137
52. CAHILL, R. J., C. J. FOLTZ, J. G. FOX, F. POWRIE u. D. B. SCHAUER (1997):
Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus.
Infect Immun 65, 3126-3131
53. KULLBERG, M. C., J. M. WARD, P. L. GORELICK, P. CASPAR, S. HIENY, A.
CHEEVERT, D. JANKOVIC u. A. SHER (1998):
Helicobacter hepaticus Triggers Colitis in Specific-Pathogen-Free Interleukin-10 (IL-10)-Deficient Mice through an IL-12- and Gamma Interferon-Dependent Mechanism Infect Immun 66, 5157-5166
54. CHIN, E. Y., C. A. DANGLER, J. G. FOX u. D. B. SCHAUERT (2000):
Helicobacter hepaticus Infection Triggers Inflammatory Bowel Disease in T Cell Receptor αβ Mutant Mice
Comp Med 50, 6
55. BURICH, A., R. HERSHBERG, K. WAGGIE, W. ZENG, T. BRABB, J. L. VINEY u.
L. MAGGIO-PRICE (2001):
Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice Gastrointestinal and Liver Physiology 281, G764-G778
56. BALISH, E. u. WARNER, T. (2002):
Enterococcus faecalis Induces Inflammatory Bowel Disease in Interleukin-10 Knockout Mice
Am J Pathol 160, 2253-2257
57. KIM, S. C., S. L. TONKONOGY, C. A. ALBRIGHT, J. TSANG, E. J. BALISH, J.
BRAUN, M. M. HUYCKE, R: B. SARTOR (2005):
Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria
Gastroenterology 128, 891-906
58. BERG, D. J., R. KÜHN, W. MÜLLER, S. MENON, G. HOLLAND, L. THOMPSON-SNIPES, M. W. LEACH u. D. RENNICK (1996):
Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses.
J Clin Invest 98, 1010-1020
59. TAKEDA, K., B. E. CLAUSEN, T. KAISHO, T. TSJIMURA, N. TERADA, I.
FÖRSTER u. S. AKIRA (1999):
Enhanced Th1 Activity and Development of Chronic Enterocolitis in Mice Devoid of Stat3 in Macrophages and Neutrophils
Immunity 10, 39-49
60. MÄHLER, M., E. LEITER, DR. (2002):
Genetic and environmental context determines the course of colitis developing in IL–
10-deficient mice
Inflammatory Bowel Disease 8, 347-355
61. BRISTOL, I. J., M. A. FARMER, X. X. ZHENG, T. B. STROM, C. O. ELSON, J. P.
SUNDBERG u. E. H. LEITER, DR. (2000):
Heritable susceptibility for colitis in mice induced by IL-10 deficiency Inflammatory Bowel Diesease 6, 290-302
62. GRÜTZ, G. (2005):
New insights into the molecular mechanism of interleukin-10-mediated immunosuppression
J Leukoc Biol 77, 3-15
63. BLEICH, A., M. MÄHLER, C. MOST, E. H. LEITER, E. LIEBLER-TENORIO, C. O.
ELSON, H. J. HEDRICH, B. SCHLEGELBERGER u. J. P. SUNDBERG (2004):
Refined histopathologic scoring system improves power to detect colitis QTL in mice Mamm Genome 15, 865-871
64. DE BUHR, M. F., M. MÄHLER, R. GEFFERS, W. HANSEN, A. M.
WESTENDORF, J. LAUBER, J. BUER, B. SCHLEGELBERGER, H. J. HEDRICH u.
A. BLEICH (2004):
Cd14, Gbp1, and Pla2g2a: three major candidate genes for experimental IBD identified by combining QTL and microarray analyses
Physiological Genomics 25, 426-434
65. DE BUHR, M. F., DR, H. J. HEDRICH, DR. A. M. WESTENDORF, F.
OBERMEIER, C. HOFMANN, DR. N.-H. ZSCHEMISCH, J. BUER, S. M. GOYERT u.
A. BLEICH (2009):
Analysis of Cd14 as a genetic modifier of experimental inflammatory bowel disease (IBD) in mice
Inflammatory Bowel Disease 15, 1824-1836
66. VAN HEEL, D. A., S. A. FISHER, A. KIRBY, M. J. DALY, J. D. RIOUX u. C. M.
LEWIS (2004):
Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs
Hum Mol Genet 13, 763-770
67. SIMMONS, D. L., S. TAN, D. G. TENEN, A. NICHOLSON-WELLER u. B. SEED (1989):
Monocyte antigen CD14 is a phospholipid anchored membrane protein Blood 73, 284-289
68. FUKATA, M., K. BREGLIO, A. CHEN, A. S. VAMADEVAN, T. GOO, S. HSU, D.
CONDUAH, R. XU u. M. T. ABREU (2008):
The Myeloid Differentiation Factor 88 (MyD88) Is Required for CD4+ T Cell Effector Function in a Murine Model of Inflammatory Bowel Disease
J Immunol 180, 1886-1894
69. DZIARSKI, R., S. VIRIYAKOSOL, T. N. KIRKLAND u. D. GUPTA (2000):
Soluble CD14 Enhances Membrane CD14-Mediated Responses to Peptidoglycan:
Structural Requirements Differ from Those for Responses to Lipopolysaccharide Infect Immun 68, 5254-5260
70. BUFLER, P., G. STIEGLER, M. SCHUCHMANN, S. HESS, C. KRÜGER, F.
STELTER, C. ECKERSKOM, C. SCHÜTT u. H. ENGELMANN (1995):
Soluble lipopolysaccharide receptor (CD14) is released via two different mechanisms from human monocytes and CD14 transfectants
Eur J Immunol 25, 604-610
71. HAZIOT, A., G. W. RONG, V. BAZIL, J. SILVER u. S. M. GOYERT (1994):
Recombinant soluble CD14 inhibits LPS-induced tumor necrosis factor- alpha production by cells in whole blood
J Immunol 152, 5868-5876
72. ABREU, M. T., P. VORA, E. FAURE, L. S. THOMAS, E. T. ARNOLD u. M.
ARDITI (2001):
Decreased Expression of Toll-Like Receptor-4 and MD-2 Correlates with Intestinal Epithelial Cell Protection Against Dysregulated Proinflammatory Gene Expression in Response to Bacterial Lipopolysaccharide
J Immunol 167, 1609-1616
73. SUZUKI, M., T. HISAMATSU u. D. K. PODOLSKY (2003):
Gamma Interferon Augments the Intracellular Pathway for Lipopolysaccharide (LPS) Recognition in Human Intestinal Epithelial Cells through Coordinated Up-Regulation of LPS Uptake and Expression of the Intracellular Toll-Like Receptor 4-MD-2 Complex
Infect Immun 71, 3503-3511
74. SAIKI, R. K., D. H. GELFAND, S. STOFFEL, S. J. SCHARF, R. HIGUCHI, G. T.
HORN, K. B. MULLIS u. H. A. ERLICH (1988):
Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase Science 239, 487-491
75. TAYLOR, J. M., R. ILLMENSEE u. J. SUMMERS (1976):
Efficient transcription of RNA into DNA by avian sarcoma virus polymerase
Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis 442, 324-330
76. BERCHTOLD, M. W. (1989):
A simple method for direct cloning and sequencing cDNA by the use of a single specific oligonucleotide and oligo(dT) in a polymerase chain reaction (PCR).
Nucleic Acids Res 17, 453
77. BIRNBOIM, H. C., u. DOLY, J. (1979):
A rapid alkaline extraction procedure for screening recombinant plasmid DNA.
Nucleic Acids Res 7, 1513-1523 78. BRADFORD, M. (1976):
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
Anal Biochem 72, 248-254 79. LAEMMLI, U. K. (1970):
Cleavage of structural proteins during the assembly of the head of Becteriophage T4 Nature
80. NASU, N., S. YOSHIDA, S. AKIZUKI, Y. HIGUCHI, M. SETOGUCHI u. S.
YAMAMOTO (1991):
Molecular and physiological properties of murine CD14 Int Immunol 3, 205-213
81. BARBOUR, S. E., C. WONG, D. RABAH, A. KAPUR u. A. D. CARTER (1998):
Mature macrophage cell lines exhibit variable responses to LPS.
Mol Immunol 35, 14-15
82. WATANABE, A., A. TAKESHITA, S. KITANO u. S. HANAZAWA (1996):
CD14-mediated signal pathway of Porphyromonas gingivalis lipopolysaccharide in human gingival fibroblasts.
Infect Immun 64, 4488-4494.
83. KITCHENS, R. L. (2000):
Role of CD14 in cellular recognition of bacterial lipopolysaccharides.
Chem Immunol 74, 61-82 84. MCANULTY, R. J. (2006):
Fibroblasts and myofibroblasts: Their source, function and role in disease Int J Biochem Cell Biol 39, 666-671
85. ODAKA, C., T. MIZUOCHI, J. YANG u. AIHAO (2003):
Protease Inhibitor During Clearance of Apoptotic Murine Macrophages Produce Secretory Leukocyte
J Immunol 171, 1507-1514
86. HOOCK, T. J., P. M. NEWCOMB u. I. M. HERMAN (1991):
Beta actin and its mRNA are localized at the plasma membrane and the regions of moving cytoplasm during the cellular response to injury.
J Cell Biol 112, 653-664
87. DE KOK; J. B., R. W. ROELOFS, B. A. GIESENDORF, J. L. PENNINGS, E. T.
WAAS, T. FEUTH, D. W. SWINKELS u. P. N. SPAN (2005):
Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes
Lab Invest 85, 154-159
88. SOKOLOVA, V., S. NEUMANN, A. KOVTUN, S. CHEMOUSOVA, R. HEUMANN u. M. EPPLE (2009):
An outer shell of positively charged poly(ethyleneimine) strongly increases the transfection efficiency of calcium phosphate/DNA nanoparticles
Journal of Materials Science 18, 4952-4957
89. ZHOU, H., H. XIONG, H. LI, S. E. PLEVY, P. D. WALDEN, M. SASSAROLI, G. D.
PRESTWICH u. J. C. UNKELESS (2004):
Microtubule-Associated Serine/Threonine p40 Synthesis and NF- kB Activation Kinase-205 kDa and Fc g Receptor Control IL-12
J Immunol 172, 2559-2568
90. BARAK, Y., M. C. NELSON, E. S. ONG, Y. Z. JONES, P. RUIZ.LOZANO, K. R.
CHIEN, A. KODER u. R. M. EVANS (1999):
PPAR gamma is required for placental, cardiac, and adipose tissue development Mol Cell 4, 585-595
91. HAARA, K., T. OKADAB, K. TOBEB, K. YASUDAC, Y. MORIB, H. KADOWAKIA, R. HAGURAA, Y. AKANUMAA, S. KIMURAB, C. ITOD u. T. KADOWAK (2000):
The Pro12Ala Polymorphism in PPAR γ2 May Confer Resistance to Type 2 Diabetes Biochemical and Biophysical Research Communications 271, 212-216
92. TONTONOZ, P., L. NAGY, J. G. A. ALVAREZ, V. A. THOMAZY u. R. M. EVANS (1998):
PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL Cell 93, 241-252
93. SU, C. G., X. WEN, S. T. BAILEY, W. JIANG, S. M. RANGWALA, S. A.
KEILBAUGH, A. FLANIGAN, S. MURTHY, M. A. LAZAR u. G. D. WU (1999):
A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response
J Clin Invest 4, 383-389
94. RICOTE, M., A. C. LI, T. M. WILLSON, C. J. KELLY u. C. K. GLASS (1998):
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation.
Nature 391, 79-82
95. GURI, A. J. u. MOHAPATRA, S. K., W. T. HORNE, R. HONTECILLAS u. J.
BASSAGANYA-RIERA (2010):
The role of T cell PPAR gamma in mice with experimental inflammatory bowel disease.
BMC Gastroenterol 10, 10-60
96. DUBUQUOY, L., E. A. JANSSON, S. DEEB, S. RAKOTOBE, M. KAROUI, J. F.
COLOMBEL, J. AUWERX, J. PETTERSSON u. P. DESREUMAUX (2003):
Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis.
Gastroenterology 124, 1265-76.
97. ANDERSEN, V., J. CHRISTENSEN, A. ERNST, B. A. JACOBSEN, A.
TJØNNELAND, H. B. KRARUP u. U. VOGEL (2011):
Polymorphisms in NF-κB, PXR, LXR, PPARγ and risk of inflammatory bowel disease.
World J Gastroenterol 17, 197-206.
98. Kim, T. H. (2011):
Transcription Factor Sp2 Regulates Growth, Differentiation, and Tumorigenesis of Epidermal Stem Cells.
NCSU State University
99. LETOURNEUR, M., L. VALENTINO, J. TRAVAGLI-GROSS, J. BERTOGLIO u. J.
PIERRE (2009):
Sp2 regulates interferon-γ-mediated socs1 gene expression Mol Immunol 46, 2151–2160
100. LEVAN, T. D., J. W. BLOOM, T. J. BAILEY, C. L. KARP, M. HALONEN, F. D.
MARTINEZ u. D. VERCELLI (2001):
A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity.
J Immunol 167, 5838-5844
101. KNIGHT, J. C. u. UDALOVA, I., A. V. S. HILL, B. M. GREENWOOD, N. PESHU, K. MARSH u. D. KWIATKOWSKI (1999):
A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria
Nat Genet 22, 145-150
102. ANNWEILER, A., S. ZWILLING, R. A. HIPSKIN u. T. WIRTH (1993):
Analysis of transcriptional stimulation by recombinant Oct proteins in a cell-free system.
J Biol Chem 268, 2525-2534.
103. WAECHTER, V., M. SCHMID, M. HEROVA, A. WEBER, V. GÜNTHER, J.
MARTI-JAUN, S. WÜST, M. RÖSINGER, C. GEMPERLE u. M. HERSBERGER (2012):
Characterization of the Promoter and the Transcriptional Regulation of the Lipoxin A4 Receptor (FPR2/ALX) Gene in Human Monocytes and Macrophages.
J Immunol 188, 1856-1867 104. DYSON, N. (1998):
The regulation of E2F by pRB-family?proteins Genes Dev 12, 2245-2262
105. WU, X. u. LEVINE, A. J. (1994):
p53 and E2F-1 cooperate to mediate apoptosis PNAS 9, 3602-3606
106. REN, B., H. CAM, Y., TAKAHASHI, T. VOLKERT, J. TERRAGNI, R. A. YOUNG u. B. D. DYNLACHT (2002):
E2F integrates cell cycle progression with DNA repair, replication, and G2/M checkpoints
Genes Dev 16, 245-256
107. LAM, E. W.-F., N. B. LA THANGUE (1994):
DP and E2F proteins: coordinating transcription with cell cycle progression Curr Opin Cell Biol 6, 859-866
108. CHEN, M., C. CAPPS, J. T. WILLERSON u. P. ZOLDHELYI (2002):
E2F-1 regulates nuclear factor-kappaB activity and cell adhesion: potential antiinflammatory activity of the transcription factor E2F-1.
Circulation 106, 2707-2713.
109. FICKENSCHER, H. R., G. CHALEPAKIS u. P. GRUSS (1993):
Murine Pax-2 protein is a sequence-specific trans-activator with expression in the genital system.
DNA Cell Biol 12, 381-391
110. DHEBI, M., M. GHAHRMANI, M. LECHNER, G. DRESSLER u. J. PELLETIER (1996):
The paired-box transcription factor, PAX2, positively modulates expression of the Wilms' tumor suppressor gene (WT1).
Oncogene 13, 447-53
111. LIU, S., R. A. SHAPIROA, S. NIEA, D. ZHUB, Y. VODOVOTZA u. T. R. BILLIAR (2000):
Characterization of rat CD14 promoter and its regulation by transcription factors AP1 and Sp family proteins in hepatocytes
Gene 250, 137-147
112. IBEAGHA-AWEMU, E. M., P. KGWATALALA, A. E. IBEAGHA u. X. ZHAO (2008):
A critical analysis of disease-associated DNA polymorphisms in the genes of cattle, goat, sheep, and pig
Mamm Genome 19, 226-245
113. MATSUURA, K., T. ISHIDA, M. SETOGUCHI, Y. HIGUCH, S. AKIZUKI u. S.
YAMAMOTO (1992):
Identification of a tissue-specific regulatory element within the murine CD14 gene.
J Biol Chem 267, 21787-21794
114. CLARK, M. E. u. MELLON, P. L. (1995):
The POU Homeodomain Transcription Factor Oct-1 Is Essential for Activity of the Gonadotropin-Releasing Hormone
Mol Cell Biol 15, 6169-6177
115. BELSHAM, D. D., u. MELLON, P. L. (2000):
Transcription Factors Oct-1 and C/EBPβ (CCAAT/Enhancer-Binding Protein-β) are Involved in the Glutamate/Nitric Oxide/cyclic-Guanosine 5′ -Monophosphate-Mediated Repression of Gonadotropin-Releasing Hormone Gene Expression Mol Endocrinol 14, 212-228
116. ZABEL, M. D., W. WHEELER, J. J. WEIS u. J. H. WEIS (2002):
Yin Yang 1, Oct1, and NFAT-4 Form Repeating, Cyclosporin-Sensitive Regulatory Modules Within the Murine CD21 Intronic Control Region1
J Immunol 168, 3341-3350
117. MORENO-ALIAGA, M. J., F. MATSUMURA (1999):
Endrin inhibits adipocyte differentiation by selectively altering expression pattern of CCAAT/enhancer binding protein-alpha in 3T3-L1 cells.
Mol Pharmacol 56, 91-101
118. GUPTA, D., T. L. JETTON, R. M. MORTENSEN, S. Z. DUAN, M. PASHAVARIA u. J. L. LEAHY (2008):
In vivo and in vitro studies of a functional peroxisome proliferator-activated receptor gamma response element in the mouse pdx-1 promoter.
J Biol Chem 283, 32462-32470
119. SHUGART, Y. Y., M. S. SILVERBERG, R. H. DUERR, K. D. TAYLOR, M.-H.
WANG, K. ZARFAS, L- P. SCHUMM, G. BROMFIELD, A. H. STEINHART, A. M.
GRIFFITHS, S. V. KANE, M. M. BARMADA, J. I. ROTTER, L. MEI, C. N.
BERNSTEIN, T. M. BAYLESS, D. LANGELIER, A. COHEN, A. BITTON, J. D. RIOUX, J. H. CHO u. S. R. BRANT (2008):
An SNP linkage scan identifies significant Crohn's disease loci on chromosomes 13q13.3 and, in Jewish families, on 1p35.2 and 3q29Inflammatory bowel disease SNP linkage scan
Genes and Immunity 9, 161-167
120. CURRAN, M. E., K. F. LAU, J. HAMPE, S. SCHREIBER, S. BRIDGER, A. J. S.
MACPHERSON, L. R. CARDON, H. SAKUL, T. J. R. HARRIS, P. STOKKERS, S. J.
H. VAN DEVENTER, M. MIRZA, A. RAEDLER, W. KRUIS, U. MECKLER, D.
THEUER, T. HERRMANN, P. GIONCHETTI, J. C. W. LEE, C. MATHEW u. J.
LENNARD-JONES (1998):
Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16
Gastroenterology 115, 1066-1071
121. HAMPE, J., S. SCHREIBER, S. H. SHAW, K. F. LAU, S. BRIDGER, A. J. S.
MACPHERSON, L. R. CARDON, H. SAKUL, T. J. R. HARRIS, A. BUCKLER, J.
HALL, P. STOKKERS, S: J. H. VAN DEVENTER, P. NÜRNBERG, M. M. MIRZA, J.
C. W. LEE, J. E. LENNARD-JONES, C. G. MATHEW u. M. E. CURRAN (1999):
A Genomewide Analysis Provides Evidence for Novel Linkages in Inflammatory Bowel Disease in a Large European Cohort
Am J Hum Genet 64, 808-816
122. DUERR, R. H., M. M. BARMADA, L. ZHANG, R. PFÜTZER u. D. E. WEEKS (2000):
High-Density Genome Scan in Crohn Disease Shows Confirmed Linkage to Chromosome 14q11-12
Am J Hum Genet 66, 1857-1862
123. YANG, H., J. D. OHMEN, Y. MA, L. G. BENTLEY, S. R. TARGAN, N. FISCHEL-GHODSIAN u. J. I. ROTTER (1999):
Additional evidence of linkage between Crohn's disease and a putative locus on chromosome 12.
Genet Med 1, 194-198
124. PARKES, M., M. M. BARMADA, J. SATSANGI, D. E. WEEKS, D. P. JEWELL u.
R. H. DUERR (2000):
The IBD2 Locus Shows Linkage Heterogeneity between Ulcerative Colitis and Crohn Disease
Am J Hum Genet 67, 1605-1610
125. HANCOCK, L., MRCS, J. BECKLEY, MRCP, A. GEREMIA, M. D., R. COONEY, MRCP, F. CUMMINGS, MRCP, S. PATHAN, D. PHIL., C. GUO, M. D., B. F.
WARREN, FRC PATH., N. MORTENSEN (FRCS, T. AHMAD, D. PHIL. U. D.
JEWELL, D. PHIL. (2008):
Clinical and molecular characteristics of isolated colonic Crohn's disease Inflammatory Bowel Disease 14, 1667-1677
126. DE LA CONCHA, E. G., M. FERNADEZ-ARQUERO, A. MARTINEZ, P. VIGIL, F.
VIDAL, G. LOPEZ-NEVE, M. DIAZ-RUBIO u. J. GARCIA-PAREDES (1999):
Amino Acid Polymorphism at Residue 71 in HLA-DR Beta Chain Plays a Critical Role in Susceptibility to Ulcerative Colitis
Dig Dis Sci 44, 2324-2329
127. NEWMA, B., M. D., M. S. SILVERBERG, M. D., X. Gu, M. SC., Q. ZHANG, M.
D., A. LAZARO, PH. D., A. H. STEINHART, M. D., G. R. GREENBERG, M. D. u. A.
M. GRIFFITHS (2004):
CARD15 and HLA DRB1 Alleles Influence Susceptibility and Disease Localization in Crohn's Disease
Am J Gastroenterol 99, 306-315
128. O’CALLAGHAN, N. J., K. E. ADAMS, E. J. WALKER, D. A. VAN HEEL u. J. A.
128. O’CALLAGHAN, N. J., K. E. ADAMS, E. J. WALKER, D. A. VAN HEEL u. J. A.